Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1987 1
1988 1
1990 2
1991 2
1992 7
1993 2
1994 5
1995 3
1996 3
1997 4
1998 5
1999 10
2000 3
2001 5
2002 3
2003 5
2004 4
2005 5
2006 3
2007 5
2008 10
2009 7
2010 8
2011 11
2012 14
2013 4
2014 8
2015 11
2016 9
2017 11
2018 15
2019 15
2020 10
2021 11
2022 16
2023 14
2024 7
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

223 results

Results by year

Filters applied: . Clear all
Page 1
FVIII half-life products: A real-world experience.
Zanon E, Porreca A, Napolitano A, Simion C, Simioni P. Zanon E, et al. Thromb Res. 2025 May;249:109306. doi: 10.1016/j.thromres.2025.109306. Epub 2025 Mar 14. Thromb Res. 2025. PMID: 40147314
Haemophilia and Cancer: A Literature Review.
Zanon E, Porreca A, Simioni P. Zanon E, et al. J Clin Med. 2024 Mar 19;13(6):1770. doi: 10.3390/jcm13061770. J Clin Med. 2024. PMID: 38541994 Free PMC article. Review.
Emerging drugs for the treatment of hemophilia A and B.
Morfini M, Zanon E. Morfini M, et al. Among authors: zanon e. Expert Opin Emerg Drugs. 2016 Sep;21(3):301-13. doi: 10.1080/14728214.2016.1220536. Epub 2016 Aug 22. Expert Opin Emerg Drugs. 2016. PMID: 27547884 Review.
Confronting the psychological burden of haemophilia.
Coppola A, Cerbone AM, Mancuso G, Mansueto MF, Mazzini C, Zanon E. Coppola A, et al. Among authors: zanon e. Haemophilia. 2011 Jan;17(1):21-7. doi: 10.1111/j.1365-2516.2010.02280.x. Haemophilia. 2011. PMID: 20579110 Review.
Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS).
Fischer K, Lassila R, Peyvandi F, Gatt A, Gouw SC, Hollingsworth R, Lambert T, Kaczmarek R, Carbonero D, Makris M; European HAemophilia Safety Surveillance (EUHASS) participants. Fischer K, et al. Res Pract Thromb Haemost. 2024 May 27;8(4):102461. doi: 10.1016/j.rpth.2024.102461. eCollection 2024 May. Res Pract Thromb Haemost. 2024. PMID: 39026659 Free PMC article.
223 results